This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Pfizer made changes to its DEI webpage, joining other companies across different...
A new CDC report adds to evidence that the HPV vaccine, once called dangerous by...
President Trump is looking for drugmakers to come through for him. They have a w...
What’s it like reporting on the FDA during the early and turbulent weeks of the ...
Why the Trump administration’s messaging on the Texas measles outbreak strikes s...
In this edition of STAT's Health Tech newsletter: Google gets an FDA clearance, ...
Government execs due to speak at the HIMSS conference next week have dropped out...
The latest biotech updates, brought to you by The Readout newsletter.
The FDA canceled an upcoming vaccine advisory committee meeting to discuss influ...
A measles death in Texas, another UnitedHealth examination, and other health new...
Why one health care investor buys “zombie” biotechs to shut them down.
The federal government’s work on long Covid has been fitful and disappointing. N...
A progressive approach to drug approval would balance the reality of drug safety...
Universities accept less than their actual overhead costs from private sources b...
Biotech venture capital is on the precipice of a generational shift. At least, t...
The advisory committee meeting is a critical resource for vaccine makers trying ...
The USDA's new plan tackles H5N1 bird flu as an issue of economic concern, and l...
Ryan said he's received complaints about scheduling, wait times, billing, and ca...
Enrollment in private Medicare Advantage plans grew just 3.1%, below projections...
A child in Texas has died from measles, the AP reported, the first death from me...
The bill would allow Medicare to begin negotiating with pharmaceutical companies...
The web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guid...
Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in th...
GenBioPro, the largest manufacturer of abortion pills in the U.S., is wading int...